Loading...

Acquisitions And Demand Will Shape Future MedTech Prospects

Published
25 Nov 24
Updated
11 Oct 25
AnalystConsensusTarget's Fair Value
SEK 268.00
11.8% undervalued intrinsic discount
11 Oct
SEK 236.40
Loading
1Y
-22.1%
7D
0.6%

Author's Valuation

SEK 26811.8% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on11 Oct 25
Fair value Decreased 5.90%

Analysts have lowered their price target for Indutrade from SEK 285 to SEK 268. This reflects more cautious expectations for the stock following recent downgrades and a reassessment of fair value assumptions.

Shared on27 Sep 25
Fair value Decreased 6.32%

The downward revision in Indutrade’s analyst price target primarily reflects a lower future P/E multiple, with no material change in the discount rate, resulting in a new fair value estimate of SEK284.80. What's in the News Indutrade will hold an Analyst/Investor Day to update on its strategy and priorities for continued sustainable profitable growth.

Shared on01 May 25
Fair value Decreased 12%

Shared on23 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Increased 2.84%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on12 Mar 25
Fair value Increased 11%

AnalystConsensusTarget has increased revenue growth from 5.4% to 8.0%.